 |
 |
 |
| |
Mikael Ørum,
Partner |
 |
 |
| |
Peter
Damsbo, MD,
Partner |
 |
 |
| |
Robert L. Buchanan , PhD,
Attorney at Law, Partner |
|
Martin Austin,
Partner
|
 |
 |
| |
Dede Willis, BSc, MBA,
Partner |
 |
 |
| |
Christina Wagner, PhD, Partner |
 |
 |
| |
Mirko
Stange, PhD,
Partner |
 |
 |
| |
Madeline
Yap, PhD,
Partner |
 |
 |
| |
Konstantinos Alevizopoulos, PhD, Partner |
 |
 |
| |
Spencer Ma MBA, FCPA, ACIS ,
Partner |
 |
 |
| |
Bengt Westrin, PhD, Assoc. Professor,
Partner |
 |
 |
| |
Pieter
Telleman, PhD, MBA,
Senior Advisor |
 |
 |
| |
Lars Hedbys,
M Sc, PhD,
Senior Advisor |
 |
 |
|
 |
| |
| |
|
|
Our Team
Madeline
Yap |
Partner
Dr. Madeline Yap joined Ventac Partners as Partner in November
2009.
Prior to Ventac, Dr. Yap held industry positions at Quintiles,
a global leader in pharmaceutical contract research services,
and Covance, one of the world’s most comprehensive drug
development services companies. In Hong Kong she was engaged
as the Commercialization & Development Manager at the technology
transfer company of the University of Hong Kong; Assistant Director
at the Biopharmaceutical Development Centre; and, the Business
Director, Greater China at an international medical communications
and marketing firm.
Dr. Yap brings extensive experience gained in Asia and Australia
including proven cross-cultural operations and management skills.
She has expertise in bringing together both the scientific research
and commercial worlds through understanding the academic demands
of innovative research projects versus the business and industrial
requirements needed for success.
Dr. Yap received her PhD in Pharmacology from the University of
Sydney, Australia. Also, she holds post-graduate management qualifications
from the Macquarie Graduate School of Management, Sydney and
Certificates in TCM from Xiamen University, China.
|
|

Madeline Yap
Partner |
|
|